Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1118541

Cover Image

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1118541

Molecular Imaging Agents to 2028

PUBLISHED:
PAGES:
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3850
PDF (Site License)
USD 5500
PDF (Global License)
USD 7500

Add to Cart

Imaging agents that function at the Molecular and Cellular Level

The ability of molecular imaging agents to improve diagnostic and treatment capabilities is now driving a directed effort to develop new agents with enhanced specificity. To sense biological processes such as gene expression, angiogenesis, apoptosis or cell trafficking in vivo, imaging reporter agents that interact specifically with molecular targets and appropriate imaging systems are currently under development. Molecular imaging will greatly reduce the need for animal tissue sampling or human biopsy when studying the progression of a disease or the follow-up of a gene therapy. It has the advantage of being non-invasive, and because it can be repeated many times, it provides both spatial and temporal dimensions to the understanding of the gene expression of the disease or therapy.

What You Will Learn:

  • Analyzes molecular imaging agents by category, target and method of detection, and assesses their capabilities, benefits, limitations and potential
  • Examines evolving imaging market segments and their impact on the diagnostic imaging sector
  • Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets
  • Profiles market participants, their development activity and business strategies
  • Evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents
Product Code: MJA577K

Table of Contents

  • Executive Summary
  • The Evolving Diagnostic Imaging Market
  • Imaging Agent Product Segments
  • Antibodies
  • Conjugated Radioisotopes
  • Metabolic Biomarkers
  • Optical Probes
  • Nanoparticles
  • Targeted Imaging Agents
  • Activatable Imaging Agents
  • Evolution in Imaging Agent Market Segments
  • Disease Detection
  • Image-Guided Drug Delivery
  • Physiological Process Mapping
  • Therapeutic Screening
  • Treatment Assessment
  • Differential Diagnosis
  • Molecular Imaging Agents & Imaging Modalities
  • MRI
  • Optical Imaging
  • PET
  • SPECT
  • Ultrasound
  • Agent Categories
  • Affibodies
  • Antibody Fragments
  • Antibodies Targeting Immune Factors
  • mAbs
  • Chimeric mAbs
  • Nanoparticles
  • Clinical Applications
  • Apoptosis
  • Cardiology
  • Angiogenesis
  • Adenosine Receptors
  • Vascular Endothelial Growth Factor Receptors
  • Immunology
  • Autoimmunity & Inflammation
  • Metabolic
  • Diabetes
  • Neurology
  • Amyloid Peptides
  • Peripheral Benzodiazepine Receptors
  • Dopamine Receptors
  • Metabotropic Glutamate
  • Norepinephrine Transporter
  • P-glycoprotein Transporter
  • Serotonin Receptors
  • Serotonin Transporter
  • Cannabinoid Receptors
  • Oncology
  • Estrogen Receptor
  • Glucose Transporters
  • L-Type Amino Acid Transporter
  • Matrix Metalloproteinase
  • Melanocortin-1
  • Prostate-specific Membrane Antigen (PSMA)
  • Sigma Receptors
  • Somatostatin Receptors
  • Market Factors
  • Guidance, Rules and Regulations
  • FDA
  • Company Profiles
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!